Recce Pharmaceuticals Ltd.
[WKN: A2ADQM | ISIN: AU000000RCE5]
Aktienkurse
0,291€ -0,68%
Echtzeit-Aktienkurs Recce Pharmaceuticals Ltd.
Bid: Ask:

Echtzeit-Chart der Recce Pharmaceuticals Ltd. Aktie

Recce Pharmaceuticals Ltd. Chart

Charttool öffnen

Börsenkurse Recce Pharmaceuticals Ltd.

Börse Stuttgart - - - - 0,270€ 0,75%
Tradegate - - - - 0,291€ -3,64%
gettex - - - - 0,291€ -0,68%

Profil der Recce Pharmaceuticals Ltd. Aktie

Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. It produces antibiotics that are effective in attacking disease-causing Gram-positive and Gram-negative bacteria. The company was founded on April 11, 2007 and is headquartered in Sydney, Australia.